Cargando…

Predictors of Willingness to Enroll in Hypothetical Alzheimer Disease Biomarker Studies that Disclose Personal Results

INTRODUCTION: We examined factors related to willingness to enroll in hypothetical Alzheimer disease (AD) biomarker studies. METHODS: Using linear regression, we assessed the relationship among enrollment willingness and demographics, family dementia history, research attitudes, concern about AD, ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Erickson, Claire M., Chin, Nathaniel A., Ketchum, Frederick B., Jonaitis, Erin M., Zuelsdorff, Megan L., Gleason, Carey E., Clark, Lindsay R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132241/ https://www.ncbi.nlm.nih.gov/pubmed/35125399 http://dx.doi.org/10.1097/WAD.0000000000000490

Ejemplares similares

Predictors of positive or negative reactions to learning Alzheimer’s biomarker results
por: Erickson, Claire, et al.
Publicado: (2021)

What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer’s Disease Biomarker Research? A Qualitative Vignette Analysis
por: Ketchum, Fred B., et al.
Publicado: (2022)

Anticipated reactions to learning Alzheimer’s disease biomarker results
por: Clark, Lindsay R., et al.
Publicado: (2022)

Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society
por: Erickson, Claire M., et al.
Publicado: (2022)

The importance of the dyad: Participant perspectives on sharing biomarker results in Alzheimer's disease research
por: Ketchum, Fred B., et al.
Publicado: (2023)

Research Participant Interest in Alzheimer’s Disease Biomarker Disclosure
por: Erickson, Claire, et al.
Publicado: (2020)

Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing
por: Ketchum, Fred B., et al.
Publicado: (2022)

Parent and Medical Professional Willingness to Enroll Children in a Hypothetical Pediatric Optic Neuritis Treatment Trial
por: Waldman, Amy T., et al.
Publicado: (2011)

Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know
por: Erickson, Claire M., et al.
Publicado: (2021)

Associations between self-reported sleep patterns and health, cognition and amyloid measures: results from the Wisconsin Registry for Alzheimer’s Prevention
por: Du, Lianlian, et al.
Publicado: (2023)

“I” Am Willing to Disclose, but “We” are Unwilling: The Impact of Self-Construal on Individuals’ Willingness to Disclose
por: Zhang, Changqing, et al.
Publicado: (2021)

Validity Evidence for the Research Category, “Cognitively Unimpaired – Declining,” as a Risk Marker for Mild Cognitive Impairment and Alzheimer’s Disease
por: Langhough Koscik, Rebecca, et al.
Publicado: (2021)

Self-reported health behaviors and longitudinal cognitive performance in late middle age: Results from the Wisconsin Registry for Alzheimer’s Prevention
por: Mueller, Kimberly D., et al.
Publicado: (2020)

Effects of disclosing hypothetical genetic test results for salt sensitivity on salt restriction behavior
por: Takeshima, Taro, et al.
Publicado: (2013)

Randomized controlled trial: Quantifying the impact of disclosing uncertainty on adherence to hypothetical health recommendations
por: Mendoza, Hannah, et al.
Publicado: (2022)

Alzheimer's disease biomarkers in Black and non‐Hispanic White cohorts: A contextualized review of the evidence
por: Gleason, Carey E., et al.
Publicado: (2021)

Cardiology clinic patient attitudes toward and potential personal utility of genetic testing: Findings from a unique multiracial clinical sample
por: Erickson, Claire M., et al.
Publicado: (2022)

Estimating willingness-to-pay for neonicotinoid-free plants: Incorporating pro-environmental behavior in hypothetical and non-hypothetical experiments
por: Wei, Xuan, et al.
Publicado: (2021)

Assessing the willingness of patients’ companions to disclose bad news to cancer patients
por: Zardoui, Arshia, et al.
Publicado: (2022)

Recruitment and retention of underrepresented populations in Alzheimer's disease research: A systematic review
por: Gilmore-Bykovskyi, Andrea L., et al.
Publicado: (2019)

Acceptability and Willingness-to-Pay for a Hypothetical Ebola Virus Vaccine in Nigeria
por: Ughasoro, Maduka Donatus, et al.
Publicado: (2015)

Trust and digital privacy: willingness to disclose personal information to banking chatbot services
por: Lappeman, James, et al.
Publicado: (2022)

The Willingness to Pay for a Hypothetical Vaccine for the Coronavirus Disease 2019 (COVID-19)
por: Tsutsui, Yoshiro, et al.
Publicado: (2021)

Psychological well-being and cognitive aging in Black, Native American, and White Alzheimer’s Disease Research Center participants
por: Wyman, Mary F., et al.
Publicado: (2022)

To disclose, or not to disclose? Context matters
por: Rahimzadeh, Vasiliki, et al.
Publicado: (2015)

Measurement batch differences and between‐batch conversion of Alzheimer's disease cerebrospinal fluid biomarker values
por: Ma, Yue, et al.
Publicado: (2021)

Willingness-to-pay for a hypothetical Ebola vaccine in Indonesia: A cross-sectional study in Aceh
por: Mudatsir, Mudatsir, et al.
Publicado: (2023)

Willingness and Predictors of Bystander CPR Intervention in the COVID-19 Pandemic: A Survey of Freshmen Enrolled in a Japanese University
por: Mori, Yukihiro, et al.
Publicado: (2022)

Disclosing genetic risk for Alzheimer's dementia to individuals with mild cognitive impairment
por: Christensen, Kurt D., et al.
Publicado: (2020)

An experimental examination of alcohol consumption, alcohol expectancy, and self‐blame on willingness to report a hypothetical rape
por: Flowe, Heather D., et al.
Publicado: (2017)

United States Travelers’ Concern about Zika Infection and Willingness to Receive a Hypothetical Zika Vaccine
por: Vielot, Nadja A., et al.
Publicado: (2018)

The acceptance and willingness to pay (WTP) for hypothetical dengue vaccine in Penang, Malaysia: a contingent valuation study
por: Yeo, Hui Yee, et al.
Publicado: (2018)

Willingness to Pay for a Hypothetical COVID-19 Vaccine in the United States: A Contingent Valuation Approach
por: Catma, Serkan, et al.
Publicado: (2021)

Feasibility of virtual Alzheimer's biomarker disclosure: Findings from an observational cohort
por: Erickson, Claire M., et al.
Publicado: (2023)

Association of the COVID-19 Outbreak With Patient Willingness to Enroll in Cancer Clinical Trials
por: Fleury, Mark E., et al.
Publicado: (2020)

The Area Deprivation Index: A novel tool for harmonizable risk assessment in Alzheimer's disease research
por: Zuelsdorff, Megan, et al.
Publicado: (2020)

Exploring Factors Associated with Chinese-Americans’ Willingness to Receive an Additional Hypothetical Annual Dose of the COVID-19 Vaccine
por: Li, Ming, et al.
Publicado: (2023)

Hypothetical questionnaires may overestimate willingness to participate in HIV cure research: Comparison of a cross-sectional survey to actual willingness to participate in an HIV cure study in the Netherlands
por: Prins, Henrieke A.B., et al.
Publicado: (2020)

The Impact of Educational Intervention on Willingness to Enroll in a Clinical Trial of a Gonorrhea Vaccine
por: Penlington, Michael, et al.
Publicado: (2023)

Singular cases of Alzheimer’s disease disclose new and old genetic “acquaintances”
por: Coppola, Cinzia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_eh837kvqevqrh8j7elk8lehiud